HYUNDAI HOPE ON WHEELS ANNOUNCES 2022 GRANT AWARD WINNERS
27 Sep 2022
During National Childhood Cancer Awareness Month, Hyundai Hope On Wheels to Present 75 Research and Programmatic Grants Totaling $15 Million
This Year's $15 million in Research and Programmatic Grants Brings the Organization's Lifetime Donation Total to $200 Million
FOUNTAIN VALLEY, Calif., Sept. 27, 2022 /PRNewswire/ -- Hyundai Hope On Wheels, a 501(c)(3) nonprofit organization supported by Hyundai Motor America and its more than 820 U.S. dealers, today announced the 2022 winners of its annual research and programmatic grants totaling $15 million. This year, Hyundai Hope On Wheels will present a total of 75 grants to institutions across the United States that are focused on improving outcomes and treatments for children diagnosed with cancer, including 25 Hyundai Scholar Hope Grants at $300,000 each, 25 Hyundai Young Investigator Grants at $200,000 each, and 25 Hyundai Impact Grants at $100,000 each.
Continue Reading
Preview
Source: PRNewswire
Hyundai Hope On Wheels 2022-2024 National Youth Ambassador Oliver Foster is photographed at Children's National Hospital in Washington D.C. on September 19, 2022 (Photo/Hyundai)
"We are honored to present this year's grant winners with funds to perform their lifesaving work and continue to bring hope to the brave pediatric cancer fighters and their families across the nation," said John Guastaferro, executive director, Hyundai Hope On Wheels. "This year's theme is 'Powered by Hope,' paying homage to the children battling cancer who inspire our organization's mission and to the doctors and researchers dedicated to finding a cure for the disease. Congratulations to this year's grant award winners and we thank you for sharing in the commitment to ensure that every child battling cancer has a fighting chance."
Since its inception in 1998, Hyundai Hope On Wheels has awarded more than 1,100 research grants funding critical research to help save young lives. This year marks Hyundai's 24th consecutive year in the fight against childhood cancer, making it one of the longest-running corporate social responsibility efforts in the automotive industry and a leading funder of pediatric cancer research in the country.
The Hyundai Scholar Hope Grants and the Hyundai Young Investigator Grants are awarded to eligible Children's Oncology Group (COG) member institutions through a competitive peer-reviewed process. Applications are reviewed by the Hyundai Hope On Wheels Medical Advisory Committee, which is comprised of leading pediatric oncologists from children's hospitals and research institutions nationwide. The Hyundai Impact Grants provide funding to children's hospitals for either childhood cancer research projects or programmatic initiatives such as clinical care.
This year, select grants will be officially presented during a Hyundai Hope On Wheels Handprint Ceremony, the nonprofit's signature event in which children impacted by cancer dip their hands in paint and place their handprints on a Hyundai vehicle, symbolizing their fight against pediatric cancer and hope for a cure.
To view learn more about Hyundai Hope On Wheels, please visit HyundaiHopeOnWheels.org.
Hyundai Scholar Hope Grant Winners ($300,000)
Hyundai Young Investigator Grant Winners ($200,000)
Hyundai Impact Grant Winners ($100,000)
Hyundai Hope On Wheels
Hyundai Hope On Wheels® is a 501(c)(3) nonprofit organization that is committed to finding a cure for childhood cancer. Launched in 1998, Hyundai Hope On Wheels provides grants to eligible institutions nationwide that are pursuing critical research aimed at improving treatments and saving lives. Hyundai Hope On Wheels is one of the largest nonprofit funders of pediatric cancer research in the country. Primary funding for Hyundai Hope On Wheels comes from Hyundai Motor America and its more than 820 U.S. dealers. Since its inception, Hyundai Hope On Wheels has pledged $200 million in support of more than 1,100 childhood cancer research grants.
SOURCE Hyundai Hope On Wheels
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.